APO RESEARCH · REPORT
Octreotide
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Product & engineering
Understand the product.
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Selected research
Industry Research
Octreotide Industry Research Report 2026
Market perspective
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
Read the full market overview
Report Scope
This report quantifies the global Octreotide market in terms of revenue (US$ million) and, where applicable, sales volume (Gram), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Gram) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Octreotide Market by Company
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Octreotide Segment by Type
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Octreotide Segment by Application
Treating Severe Diarrhea
Treating Acromegaly
Others
Octreotide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Octreotide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Octreotide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Octreotide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Octreotide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Octreotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Octreotide Injection
- Octreotide Powder
- Octreotide Microspheres
Applications
- Treating Severe Diarrhea
- Treating Acromegaly
- Others
Companies covered
- Novartis
- Sun Pharmaceutical
- Chengdu Tiantaishan pharmaceutical
- Sinopharm A-Think Pharmaceuticals
- Sihuan Pharmaceutical Holdings Group
- Shanghai Soho-Yiming Pharmaceuticals
- Yibin Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Octreotide Market Size (2021-2032)
- 2.2.2 Global Octreotide Sales (2021-2032)
- 2.2.3 Global Octreotide Market Average Price (2021-2032)
- 2.3 Octreotide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Octreotide Injection
- 2.3.3 Octreotide Powder
- 2.3.4 Octreotide Microspheres
- 2.4 Octreotide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Treating Severe Diarrhea
- 2.4.3 Treating Acromegaly
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Octreotide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Octreotide Sales (Gram) of Manufacturers (2021-2026)
- 3.3 Global Octreotide Revenue of Manufacturers (2021-2026)
- 3.4 Global Octreotide Average Price by Manufacturers (2021-2026)
- 3.5 Global Octreotide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Octreotide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Octreotide, Product Type & Application
- 3.8 Global Manufacturers of Octreotide, Established Date
- 3.9 Global Octreotide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis
- 4.1.1 Novartis Company Information
- 4.1.2 Novartis Business Overview
- 4.1.3 Novartis Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis Octreotide Product Portfolio
- 4.1.5 Novartis Recent Developments
- 4.2 Sun Pharmaceutical
- 4.2.1 Sun Pharmaceutical Company Information
- 4.2.2 Sun Pharmaceutical Business Overview
- 4.2.3 Sun Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharmaceutical Octreotide Product Portfolio
- 4.2.5 Sun Pharmaceutical Recent Developments
- 4.3 Chengdu Tiantaishan pharmaceutical
- 4.3.1 Chengdu Tiantaishan pharmaceutical Company Information
- 4.3.2 Chengdu Tiantaishan pharmaceutical Business Overview
- 4.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio
- 4.3.5 Chengdu Tiantaishan pharmaceutical Recent Developments
- 4.4 Sinopharm A-Think Pharmaceuticals
- 4.4.1 Sinopharm A-Think Pharmaceuticals Company Information
- 4.4.2 Sinopharm A-Think Pharmaceuticals Business Overview
- 4.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio
- 4.4.5 Sinopharm A-Think Pharmaceuticals Recent Developments
- 4.5 Sihuan Pharmaceutical Holdings Group
- 4.5.1 Sihuan Pharmaceutical Holdings Group Company Information
- 4.5.2 Sihuan Pharmaceutical Holdings Group Business Overview
- 4.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio
- 4.5.5 Sihuan Pharmaceutical Holdings Group Recent Developments
- 4.6 Shanghai Soho-Yiming Pharmaceuticals
- 4.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
- 4.6.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
- 4.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio
- 4.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
- 4.7 Yibin Pharmaceutical
- 4.7.1 Yibin Pharmaceutical Company Information
- 4.7.2 Yibin Pharmaceutical Business Overview
- 4.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Yibin Pharmaceutical Octreotide Product Portfolio
- 4.7.5 Yibin Pharmaceutical Recent Developments
5 Global Octreotide Market Scenario by Region
- 5.1 Global Octreotide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Octreotide Sales by Region: 2021-2032
- 5.2.1 Global Octreotide Sales by Region: 2021-2026
- 5.2.2 Global Octreotide Sales by Region: 2027-2032
- 5.3 Global Octreotide Revenue by Region: 2021-2032
- 5.3.1 Global Octreotide Revenue by Region: 2021-2026
- 5.3.2 Global Octreotide Revenue by Region: 2027-2032
- 5.4 North America Octreotide Market Facts & Figures by Country
- 5.4.1 North America Octreotide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Octreotide Sales by Country (2021-2032)
- 5.4.3 North America Octreotide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Octreotide Market Facts & Figures by Country
- 5.5.1 Europe Octreotide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Octreotide Sales by Country (2021-2032)
- 5.5.3 Europe Octreotide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Octreotide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Octreotide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Octreotide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Octreotide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Octreotide Market Facts & Figures by Country
- 5.7.1 South America Octreotide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Octreotide Sales by Country (2021-2032)
- 5.7.3 South America Octreotide Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Octreotide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Octreotide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Octreotide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Octreotide Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Octreotide Sales by Type (2021-2032)
- 6.1.1 Global Octreotide Sales by Type (2021-2032) & (Gram)
- 6.1.2 Global Octreotide Sales Market Share by Type (2021-2032)
- 6.2 Global Octreotide Revenue by Type (2021-2032)
- 6.2.1 Global Octreotide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Octreotide Revenue Market Share by Type (2021-2032)
- 6.3 Global Octreotide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Octreotide Sales by Application (2021-2032)
- 7.1.1 Global Octreotide Sales by Application (2021-2032) & (Gram)
- 7.1.2 Global Octreotide Sales Market Share by Application (2021-2032)
- 7.2 Global Octreotide Revenue by Application (2021-2032)
- 7.2.1 Global Octreotide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Octreotide Revenue Market Share by Application (2021-2032)
- 7.3 Global Octreotide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Octreotide Value Chain Analysis
- 8.1.1 Octreotide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Octreotide Production Mode & Process
- 8.2 Octreotide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Octreotide Distributors
- 8.2.3 Octreotide Customers
9 Global Octreotide Analyzing Market Dynamics
- 9.1 Octreotide Industry Trends
- 9.2 Octreotide Industry Drivers
- 9.3 Octreotide Industry Opportunities and Challenges
- 9.4 Octreotide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst